逸達生物科技 Foresee Pharmaceuticals Co., Ltd.

  • About Us
    • Company Profile
    • Business Model
    • Board of Directors
    • Management Team
    • Company Partners
    • Scientific Advisory Board
    • Others
  • R & D
    • Pipeline Overview
    • SIF Pipeline
      • FP-001：Prostate Cancer
      • FP-004：Opioid Dependence/Pain
      • FP-011：Breast Cancer/Prostate Cancer
      • FP-014：Breast Cancer/Prostate Cancer
      • FP-015：Neurology
      • Other Research Projects
    • NCE Pipeline
      • FP-045: Fanconi Anemia
      • FP-025：Asthma and COPD; ARDS in COVID-19 Patients
      • FP-040: CNS Diseases
      • FP-020: Alport Syndrome
  • Media
    • Press Release
    • Media Library
  • Investors
    • Corporate Governance
      • Corporate Structure
      • Board of Directors
      • Corporate Charters
      • Others
    • Material Information
    • News & Events
      • Press Releases
      • Events & Presentations
    • Financial Information
      • Financial Results
      • Monthly Revenues
    • Sharholder Information
      • Annual General Meeting
      • Major Shareholders
      • FAQs
      • Investor Contacts
    • Others
  • Career
    • WELFARE & BENEFITS
    • Join Us
  • Contact Us
  • 繁體中文
  • HOME

  • Press Release

  • Pipeline Overview

  • Financial Information

  • Company Partners

Foresee Pharmaceuticals Co., Ltd.

Address：9F-2., No.19-3, Sanchong Rd., Nangang Dist., Taipei City 115, Taiwan
                550 S college Ave, Suite 107, Newark, DE 19713, USA
Tel：+886-2-77500188(TW)  302-366-1785(USA)　Fax：+886-2-77500199(TW) 302-366-1806(USA)
Copyright © 2013. Foresee Pharmaceuticals Co., Ltd. All rights reserved.